
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+11
Neuron23TM Inc. is a leading clinical-stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases. Neuron23 combines recent advances in human genetics with a state-of-the-art drug discovery and biomarker platform using advanced techniques in machine learning and artificial intelligence to advance therapeutics for devastating diseases. The Companys focus areas are neurodegenerative diseases, neuroinflammatory diseases, and systemic autoimmune and inflammatory diseases. Founded in 2018, Neuron23 has assembled a world-class team of experts and entrepreneurs located in South San Francisco, CA
Biotech,precision medicine,immunological diseases,neurological diseases,neurodegenerative diseases,neuroinflammatory diseases,autoimmune diseases,inflammatory diseases,human genetics,data science,parkinson's disease,crohn's disease,ulcerative colitis,psoriasis,ibd,and ankylosing spondylitis
Neuron23 operates in the Biotechnology research industry.
Neuron23's revenue is 11m - 100m
Neuron23 has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.